Table of Content




1. Executive Summary


2. Global Subunit Vaccine Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges 


3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Subunit Vaccine Market Trends (2018-2023) and Forecast (2024-2030)

3.3: Global Subunit Vaccine Market by Product Type
3.3.1: Protein Antigen
3.3.2: Polysaccharide Antigen

3.4: Global Subunit Vaccine Market by Disease
3.4.1: Infectious Disease
3.4.2: Diphtheria
3.4.3: Tetanus and Pertussis (DTP)
3.4.4: HPV
3.4.5: Measles
3.4.6: Mumps and Rubella (MMR)
3.4.7: Others





4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Subunit Vaccine Market by Region
4.2: North American Subunit Vaccine Market
4.2.2: North American Subunit Vaccine Market by Disease: Infectious Disease, Diphtheria, Tetanus and Pertussis (DTP), HPV, Measles, Mumps and Rubella (MMR), and Others


4.3: European Subunit Vaccine Market
4.3.1: European Subunit Vaccine Market by Product Type: Protein Antigen and Polysaccharide Antigen
4.3.2: European Subunit Vaccine Market by Disease: Infectious Disease, Diphtheria, Tetanus and Pertussis (DTP), HPV, Measles, Mumps and Rubella (MMR), and Others


4.4: APAC Subunit Vaccine Market
4.4.1: APAC Subunit Vaccine Market by Product Type: Protein Antigen and Polysaccharide Antigen
4.4.2: APAC Subunit Vaccine Market by Disease: Infectious Disease, Diphtheria, Tetanus and Pertussis (DTP), HPV, Measles, Mumps and Rubella (MMR), and Others


4.5: ROW Subunit Vaccine Market
4.5.1: ROW Subunit Vaccine Market by Product Type: Protein Antigen and Polysaccharide Antigen
4.5.2: ROW Subunit Vaccine Market by Disease: Infectious Disease, Diphtheria, Tetanus and Pertussis (DTP), HPV, Measles, Mumps and Rubella (MMR), and Others



5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis


6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Subunit Vaccine Market by Product Type
6.1.2: Growth Opportunities for the Global Subunit Vaccine Market by Disease

6.1.3: Growth Opportunities for the Global Subunit Vaccine Market by Region

6.2: Emerging Trends in the Global Subunit Vaccine Market

6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Subunit Vaccine Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Subunit Vaccine Market
6.3.4: Certification and Licensing


7. Company Profiles of Leading Players
7.1: GE Healthcare Life Sciences
7.2: GlaxoSmithKline
7.3: Merck
7.4: Reber Genetics
7.5: Sanofi
7.6: Algenex
7.7: Astellas Pharma